Current filters:

Advair Diskus

1 to 9 of 119 results

Mylan starts Ph III trials for generics of Advair Diskus and insulin analog to Lantus


US generic drugs major Mylan says it is initiating Phase III clinical trials for its generic version…

Advair DiskusDiabetesGenericsGlaxoSmithKlineLantusMylanResearchRespiratory and PulmonarySanofi

Positive results from Anoro Ellipta vs Seretide and Advair Diskus in patients in COPD

Positive results from Anoro Ellipta vs Seretide and Advair Diskus in patients in COPD


GlaxoSmithKline and Theravance today announced positive results from three Phase III studies with their…

Advair DiskusAnoro ElliptaGlaxoSmithKlinePharmaceuticalResearchRespiratory and PulmonarySeretide

Mylan to acquire Pfizer generic respiratory delivery platform; challenge to GSK


US generic drug major Mylan (Nasdaq: MYL) has entered into an agreement with global pharma behemoth Pfizer…

Advair DiskusGenericsGlaxoSmithKlineLicensingMylan LaboratoriesPfizerPharmaceuticalRespiratory and PulmonarySeretide

COPD drug sales will reach more than $13 billion in top seven markets in 2019


Through 2019, an expanding aging population and increases in diagnosis and drug treatment will fuel steady…

Advair DiskusBoehringer IngelheimGlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

SkyePharma takes back NDA for Flutiform from Abbott Labs


The UK’s drug formulation specialist SkyePharma says that the US New Drug Application for its investigation…

Abbott LaboratoriesAdvair DiskusFloventFlovent DiskusFluticasone PropionateLicensingPharmaceuticalRegulationRespiratory and Pulmonary

1 to 9 of 119 results

Back to top